Easywell Biomedicals, Inc. (TPEX:1799)
25.10
+0.20 (0.80%)
Nov 10, 2026, 1:23 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 3.13 billion as of November 9, 2026. It is the 25,256th most valuable company in the world and the 1,323rd biggest in Taiwan. Its market cap has decreased by 31.61% in one year.
Market Cap
3.13B
Enterprise Value
3.05B
Revenue
799.94M
Global Rank
Country Rank
#1,323 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 3.13B, an increase of 599.54%. That is a compound annual growth rate of 10.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 3.13B | -29.89% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 5.42B |
| Alar Pharmaceuticals | 5.14B |
| Yoda Pharmaceuticals | 4.84B |
| LIWANLI Innovation | 4.46B |
| Panion & Bf Biotech | 4.29B |
| Orient EuroPharma | 3.67B |
| Maywufa Company | 2.76B |
| Allied Biotech | 2.60B |